Le Lézard
Classified in: Science and technology
Subjects: Conference, Trade Show

Nanotronics to Present on Next Gen Semiconductor Material at Photonics West


Nanotronics, the Industrial AI company, will exhibit their updated suite of AI-powered factory control tools at the annual SPIE Photonics West, the world's premier event for lasers, biomedical optics and biophotonic technologies, quantum, and optoelectronics. The conference takes place from January 30th - February 1st. Live demonstrations of the products will be held at Booth #2050 where conference participants will have the opportunity to preview:

Valerie Bordelanne, VP of Engineering and Quality at Nanotronics, will present "Advantages of gallium oxide for novel semiconductor production and power electronics applications" and discuss the competitive advantages of this next-generation semiconductor material. Bordelanne will also address challenges encountered in Ga2O3 production processes and detail Cubefabstm, the company's latest innovation that offers a solution. Her session will take place on January 30th from 9:00-9:30AM PST.

About Valerie Bordelanne

Valerie is a twenty-year veteran of the semiconductor industry and leads quality and engineering for Nanotronics. Her career began at ST Microelectronics in France, and from there, she was with Dupont and Toppan in Singapore and China. While with Silverbrook Research in Australia, she developed a MEMS based super-fast inkjet printer and a lab on a chip device with TSMC (Taiwan). From there, she moved to Hong Kong and then Boston for Sensera Inc. As their Director of Manufacturing and Engineering, Valerie developed MEMS microdevices and microfluidic products, such as a pressure sensor that is now embedded in every heart pump, an implantable glucose sensor, a concussion detection device, and an artificial lung microfluidic chip. Valerie is a graduate of the Physics and Chemistry Graduate School of Bordeaux in France.

About Nanotronics

Nanotronics is an Industrial AI company that deploys advanced optical solutions to optimize manufacturing procedures, effectively refining, and expediting assembly for any industry relying on a precision process for production. Nanotronics uses hardware and software solutions to clean, sort, and manage existing data as well as data collected in real time across sensors placed strategically within customers' plants. This data is stored on local servers to ensure maximum security.

Nanotronics' sophisticated AI system correlates data points into actionable insights for manufacturers to correct flaws in the production process while also predicting future errors. This results in an autonomous factory that operates on autopilot to drive up yields, decrease waste, and encourage implementation of sustainability standards.


These press releases may also interest you

at 23:00
Flourish Ventures, an early-stage venture capital firm with purpose, today announced the appointment of Ravi Kaushik as Executive Director, Head of Asia Investments. Ravi will lead the global firm's fintech investments and portfolio management in...

at 22:17
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of information and communication technology solutions, today announced that it was honored with 2023 Climate...

at 22:04
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...

at 21:57
Hikvision has released its full-year 2023 financial results, reporting a total revenue of RMB 89.34 billion, up 7.42% year-over-year. Net profit attributable to shareholders of the company was RMB 14.11 billion, achieving a year-over-year (YoY)...

at 21:05
DTEN, a leading provider of video conferencing solutions, is proud to announce that their flagship All-in-One solution, the DTEN D7X series, is now available to purchase in South Korea after it has successfully passed the rigorous certification...

at 20:15
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...



News published on and distributed by: